Search

everythingexperts & clinicslearnfaqsresearchcommunity

for

Search:↓

This diagnostic discussion reports that diffuse alopecia areata was identified in a patient with diffuse hair loss, based on specific histopathological features observed in a biopsy.

Patient history is key in diagnosing hair loss types.

This case report describes a 42-year-old male with alopecia areata and a scalp neurofibroma, emphasizing the tumor's histopathological features and the patient's decision against surgical treatment.

This study found that among women with diffuse hair loss, 26.2% had a history of drug intake, with antihypertensives being the most common drug group implicated.

This review discusses the role of various hormones in diffuse hair loss and emphasizes the need for further research to clarify their complex interactions and potential therapeutic implications, but reports no new clinical results.

This case report describes a 35-year-old Taiwanese man whose hair loss improved significantly after treatment for syphilis, suggesting a link between his condition and the infection.

This case report documented alopecia as a rare complication of SARS-CoV-2 infection in a 33-year-old woman, with hair loss improving after treatment.

This study observed that patients with different types of alopecia exhibited variable epidermal thickness and consistent dermal changes, including hair follicle destruction and lymphohistiocytic infiltrates, which may suggest inflammation.

Melatonin helps hair growth in women with hair loss issues.

This study observed that triple horizontal scalp biopsies provided a more accurate diagnosis of female pattern hair loss in women than a single horizontal biopsy, especially for those with advanced hair loss.

This study found no direct relationship between low serum ferritin and chronic diffuse telogen hair loss in women, questioning the usefulness of serum ferritin measurement and iron supplementation for managing this condition.

This study observed that acute diffuse and total alopecia, a subtype of alopecia areata, typically resolves rapidly and spontaneously within about six months, even without treatment, suggesting a favorable prognosis.

This study suggests the existence of a new subtype of alopecia, called 'acute diffuse and total alopecia of the female scalp (ADTAFS)', characterized by acute, diffuse hair loss primarily in women and a rapid recovery.

This study reports that dermoscopy is a useful diagnostic tool for distinguishing acute diffuse and total alopecia of the female scalp from female pattern hair loss by identifying specific hair features.

This report describes two cases where patients developed alopecia while undergoing treatment for psoriasis with IL-17 inhibitors, suggesting an unexpected paradoxical reaction.

This study reports that nonscarring diffuse hair loss in women is most common in the 21-40 age group, with low serum ferritin, vitamin B12, and vitamin D3 levels contributing to its pathogenesis.

This article challenges the idea that low serum ferritin is not associated with chronic diffuse telogen hair loss by questioning the validity of 'normal' serum ferritin reference ranges.

In this case report, the authors describe complete recovery from acute diffuse and total alopecia linked to Borrelia infection after treatment with intravenous ceftriaxone and topical clobetasol foam.

This article describes the first reported case of alopecia in a neonate with congenital syphilis.

This study presents the first documented case of dramatic hair regrowth in a systemic lupus erythematosus patient with refractory alopecia following tofacitinib therapy, suggesting a potential new application for JAK inhibitors in difficult-to-treat cutaneous SLE manifestations.

Crohn's disease can cause hair loss before other symptoms appear.

In this study, increased Treg cell activity indicated by IL-10 and IL-15 was identified as a feature of ADTA, distinguishing it from AA and potentially explaining ADTA's more favorable prognosis.

This case report from Dr Batra’s® Homeopathy Clinic describes significant improvement in a middle-aged woman's chronic hair loss and scalp visibility through individualized homeopathic treatment, nutritional adjustments, and regular monitoring over a year, as evidenced by patient-reported outcomes and clinical assessments.

This study reports two cases where acquired perforating dermatosis was localized to the scalp and coincided with acute diffuse alopecia, suggesting perifollicular inflammation may link the two conditions.

This study found that a recent outbreak of diffuse hair loss in Maharashtra's Buldhana district was linked to anagen effluvium, possibly caused by high selenium levels, along with strontium and zinc excess in patients' serum and local water sources.

This study found that females with chronic diffuse hair loss, including chronic telogen effluvium and female pattern hair loss, had significantly lower serum ferritin levels compared to controls, suggesting a strong association between decreased iron stores and hair loss.

Treating post-COVID hair loss leads to full recovery, while not treating it often results in ongoing symptoms.

In this study, researchers analyzed histopathologic findings in 32 women with chronic diffuse alopecia and found that 40.6% had androgenetic alopecia, while a diffuse variant of lichen planopilaris was diagnosed in 32.5% of cases, emphasizing the importance of histopathologic examination for accurate diagnosis.

Increased Treg cells and IL-10 may help quick recovery in acute diffuse and total alopecia.

This case study illustrates the successful treatment of chronic diffuse telogen effluvium in a young woman attributed to latent iron deficiency and emphasizes the importance of comprehensive assessment in similar cases.